MYC and breast cancer: The results of Li et al. demonstrated that ganoderic acids of GLK suppressed growth and angiogenesis in breast cancer cells by modulating the NF-κB signaling pathway including c-Myc and cyclin D1, anti-apoptosis Bcl-2, MMP-9 and VEGF [27].